Get the Stockscreener App
1.69
3.98%
-0.07
After Hours:
1.73
0.04
+2.37%
Hookipa Pharma Inc Stock (HOOK) Latest News
Hookipa Pharma stock hits 52-week low at $1.71 amid downturn - MSN
Hookipa Pharma announces enrollment completion of Phase 1b HB-500 trial - Yahoo Finance
Hookipa Pharma Files Petition to Validate Stockholder Actions at Annual Meetings - Defense World
HOOKIPA completes enrollment for HIV vaccine trial By Investing.com - Investing.com Nigeria
HOOKIPA Pharma seeks court validation for stockholder actions By Investing.com - Investing.com Australia
HOOKIPA completes enrollment for HIV vaccine trial - Investing.com India
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b - GlobeNewswire
Game-Changing HIV Vaccine Trial Fully Enrolled: HOOKIPA's Path to Potential Cure - StockTitan
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment… - Informazione.it
Poolbeg Agrees to Bid Deadline Extension for Possible Hookipa Pharma Deal - MarketWatch
Poolbeg and HOOKIPA given more time to agree merger deal - Proactive Investors Australia
Poolbeg Pharma PLC (AIM:POLB) Offer Update – Extension to PUSU Deadline - Share Talk
Poolbeg Pharma granted extension to PUSU Deadline - DirectorsTalk Interviews
Poolbeg Pharma and HOOKIPA Extend Merger Deadline Amid Positive Discussions - TipRanks
HOOKIPA Pharma seeks court validation for stockholder actions - MSN
Hookipa Pharma Seeks Validation for Stockholder Meetings - TipRanks
HOOK (HOOKIPA Pharma) Shares Outstanding (EOP) : 12.05 Mil (As of Sep. 2024) - GuruFocus.com
Hookipa Pharma stock hits 52-week low at $1.73 amid market challenges - Investing.com Nigeria
Geode Capital Management LLC Cuts Stake in Hookipa Pharma Inc (NASDAQ:HOOK) - Defense World
HC Wainwright Reiterates Neutral Rating for Hookipa Pharma (NASDAQ:HOOK) - Defense World
HOOKIPA Pharma explores acquisition of Poolbeg Pharma By Investing.com - Investing.com South Africa
HOOKIPA Pharma explores acquisition of Poolbeg Pharma - Investing.com
Poolbeg Pharma notes Gilead interest in Hookipa fundraise -January 10, 2025 at 11:08 am EST - Marketscreener.com
Poolbeg Pharma PLC (AIM:POLB) Update Potential Combination of Poolbeg & HOOKIPA - Share Talk
Poolbeg Pharma update on potential combination with HOOKIPA - DirectorsTalk Interviews
Poolbeg Pharma plc ('Poolbeg”) and HOOKIPA Pharma Inc. ('HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA - The Manila Times
Poolbeg Pharma and HOOKIPA Explore Potential Merger Amid Gilead’s Interest - TipRanks
Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. - GlobeNewswire
Gilead Sciences Backs HOOKIPA-Poolbeg Merger Talks with $8.7M Funding Commitment - StockTitan
HOOKIPA Pharma discloses position in takeover code filing By Investing.com - Investing.com Nigeria
HOOKIPA Pharma Inc. Enters Non-Binding Discussions for Potential Acquisition of Poolbeg Pharma plc - Defense World
HOOKIPA Pharma discloses position in takeover code filing - Investing.com India
UPDATEMyriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
HOOKIPA Pharma IncFORM 8 (OPD) - GlobeNewswire
HOOKIPA Pharma Discloses Executive Stock Holdings, Awards Major RSU Grants to Leadership - StockTitan
HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements - The Manila Times
HOOKIPA Pharma Issues Key Disclosure Notice for Poolbeg Pharma Acquisition Plans - StockTitan
Poolbeg and HOOKIPA progress toward potential merger By Investing.com - Investing.com Australia
HOOKIPA Pharma in talks to acquire Poolbeg Pharma By Investing.com - Investing.com Australia
HOOKIPA Pharma in talks to acquire Poolbeg Pharma - Investing.com
HOOKHOOKIPA Pharma Inc. Latest Stock News & Market Updates - StockTitan
Poolbeg and HOOKIPA progress toward potential merger - Investing.com India
2.27%
5.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):